# Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age

> **NCT00351624** · PHASE3 · COMPLETED · sponsor: **dsm-firmenich Switzerland AG** · enrollment: 216 (actual)

## Conditions studied

- Healthy

## Interventions

- **BEHAVIORAL:** DHA
- **BEHAVIORAL:** placebo

## Key facts

- **NCT ID:** NCT00351624
- **Lead sponsor:** dsm-firmenich Switzerland AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351624, "Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00351624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*